Yosef Yarden

6PUBLICATIONS
43CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 15, 2026
Fc-Dependent Targeting of the GAS6-MERTK Axis With Monoclonal and Bispecific Antibodies Overcomes Drug Resistance Across EGFR Mutations in Exons 19, 20, and 21.

|May 12, 2026
TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens.

|Mar 04, 2021
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models.

Ilaria Marrocco, Donatella Romaniello, Itay Vaknin

|Sep 22, 2020
Proteomic patterns associated with response to breast cancer neoadjuvant treatment.

Anjana Shenoy, Nishanth Belugali Nataraj, Gili Perry

|Dec 08, 2017
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors.

Maicol Mancini, Hilah Gal, Nadège Gaborit

|Aug 04, 2016
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.

Aldema Sas-Chen, Miriam R Aure, Limor Leibovich

Pageof 1

Frequent Collaborators

2 joint publications

Yehoshua Enuka

2 joint publications

Nishanth Belugali Nataraj

2 joint publications

Roni Oren

2 joint publications

Nitin Gupta